MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0016137
Bravo Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹6.47 Cr
▲ 750% YoY
Net profit · FY 2024
₹3.78 Lakh
Net margin 0.6%
EBITDA · FY 2024
₹44.29 Lakh
EBITDA margin 6.8%
Authorised capital
₹12 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹18.68 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
About Bravo Pharmaceuticals Private Limited
Data last updated:
Bravo Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 June 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2011PTC220862. Its GSTIN is 07AAECB5734B1Z2 (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Shreekant Panday and Rakesh Pandey.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 2 3rd Floor Commercial Complex, Safdarjung Development Area, New Delhi, Delhi, India – 110016.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.47 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.78 Lakh (net margin 0.6%) and EBITDA of ₹44.29 Lakh (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹18.68 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.
Bravo Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0016137). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bravopharma.co.in.
Company details
CIN U33110DL2011PTC220862
Registration Number 220862
Incorporation Date 14 June 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0016137
Recognitions & Rankings of Bravo Pharmaceuticals
Contact details
Bravo Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is bravopharma.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC – 2 3rd Floor Commercial Complex, Safdarjung Development Area, New Delhi, Delhi, India – 110016
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bravo Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Bravo Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bravo Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bravo Pharmaceuticals Private Limited, buy the company report.
Financials of Bravo Pharmaceuticals Private Limited
FY 2024 filings availableBravo Pharmaceuticals Private Limited reported revenue of ₹6.47 Cr (up 750% YoY) for FY 2024.
Revenue · FY 2024
₹6.47 Cr ▲ 750%
Net profit · FY 2024
₹3.78 Lakh margin 0.6%
EBITDA · FY 2024
₹44.29 Lakh margin 6.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 750%
3 years · compounded
▲ 24%
5 years · compounded
▲ 3%
EBITDA CAGR growth
3 years · compounded
▲ 38%
5 years · compounded
▲ 12%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 750% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹44.29 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.78 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bravo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bravo Pharmaceuticals Private Limited
Bravo Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shreekant Panday | Director | 02 Sep 2022 | 4 Years 2 Months | Current |
| Rakesh Pandey | Director | 14 Jun 2011 | 15 Years 5 Months | Current |
| Reena Singh Also directs: Bravo Ethanol Private Limited, Bravo Research Lab Private Limited | Director | 24 Jun 2012 | 14 Years 4 Months | Current |
Peer comparison
Bravo Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alleviare Life Sciences Private Limited | ₹6.49 Cr (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Rawia International Healthcare Private Limited | ₹6.49 Cr (FY 2025) | -24.0% | Mumbai, Maharashtra, India | |||
| Daikon Pharmaceuticals Private Limited | ₹6.49 Cr (FY 2025) | 7.0% | Delhi, India | |||
| Bravo Pharmaceuticals Private Limitedthis company | ₹6.47 Cr (FY 2024) | ₹3.78 Lakh | 0.6% | 750.0% | New Delhi, Delhi, India | |
| Wasazra Pharmaceuticals Limited | ₹6.46 Cr (FY 2024) | -2.0% | Lucknow, Uttar Pradesh, India | |||
| Rheo Pharma Private Limited | ₹6.46 Cr (FY 2024) | 525.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Bravo Pharmaceuticals Private Limited, buy the company report.
Auditor
Bravo Pharmaceuticals Private Limited is audited by SVP AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SVP AND ASSOCIATES | FY 2023 | 003838N |
Shareholding
The shareholding of Bravo Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bravo Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹18.68 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Dec 2024 | 101017505 | Axis Bank Limited | ₹31.36 Lakh | Open | |
| 14 Feb 2024 | 100882278 | Others | ₹2 Cr | Open | |
| 23 Aug 2023 | 100779772 | Others | ₹14.49 Cr | Open | |
| 23 Aug 2023 | 100779776 | Others | ₹1.88 Cr | Open |
Total charge records: 4 View all charges
Legal cases
Bravo Pharmaceuticals Private Limited has 2 court cases on record: 1 filed by Bravo Pharmaceuticals, 1 filed against it. All cases are disposed.
Total cases
2
Filed by the company
1
Filed against the company
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Criminal case | Filed by the company against an individual | Disposed |
| District court, South, Delhi | Criminal case | Filed against the company by an individual | Disposed |
To see the full case history of Bravo Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Bravo Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pinkbell Constech Private Limited |
To see the full MSME payment records of Bravo Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Bravo Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECB5734B1Z2 | Delhi | Active | 01 Jul 2017 |
| 10AAECB5734B1ZF | Bihar | Active | 01 Jun 2023 |
To see the full GST registrations and return filing status of Bravo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bravo Pharmaceuticals Private Limited has 9 board changes on record since 2011: 3 appointments and 6 cessations. The latest: Shreekant Panday ceased to be Additional Director on 29 Sep 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.31 Cr with Charge ID 101017505 was registered on 12 Dec 2024.
AGM
Bravo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Shreekant Panday ceased to be Additional Director.
Filing
Bravo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi I.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100882278 was registered on 14 Feb 2024.
Charges
A charge with Others amounted to Rs. 14.49 Cr with Charge ID 100779772 was registered on 23 Aug 2023.
Charges
A charge with Others amounted to Rs. 1.88 Cr with Charge ID 100779776 was registered on 23 Aug 2023.
Appointed
Shreekant Panday was appointed as Director.
Ceased
Abha Kumar ceased to be Additional Director.
Ceased
Nishant Kumar ceased to be Director.
Ceased
Anil Kumar ceased to be Director.
Ceased
Praveen Sachdeva ceased to be Director.
4 earlier events are in the company report.
Frequently asked questions
Bravo Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 June 2011 (15+ years old) and is registered under CIN U33110DL2011PTC220862.
Bravo Pharmaceuticals has 3 current directors:
- Shreekant Panday - Director
- Rakesh Pandey - Director
- Reena Singh - Director
The latest financial statements of Bravo Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Bravo Pharmaceuticals is 07AAECB5734B1Z2, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 10AAECB5734B1ZF (Bihar).
The CIN (Corporate Identification Number) of Bravo Pharmaceuticals is U33110DL2011PTC220862. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bravo Pharmaceuticals has 2 court cases on record: 1 filed by the company and 1 filed against it.
Bravo Pharmaceuticals was incorporated on 14 June 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Bravo Pharmaceuticals by revenue are Alleviare Life Sciences Private Limited, Rawia International Healthcare Private Limited, Daikon Pharmaceuticals Private Limited, Wasazra Pharmaceuticals Limited, Rheo Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Shreekant Panday ceased to be Additional Director on 29 Sep 2024. Shreekant Panday was appointed as Director on 02 Sep 2022. Abha Kumar ceased to be Additional Director on 01 Mar 2021. Bravo Pharmaceuticals has 9 board changes on record in total.
Yes, Bravo Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0016137).
Bravo Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 02 May 2024.
Bravo Pharmaceuticals can be reached through the website bravopharma.co.in. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages